Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

16.11.2026

4 AIDS
3 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
2 Clin Infect Dis
7 HIV Med
3 J Acquir Immune Defic Syndr
1 J Clin Invest
1 J Infect Dis
3 J Virol
3 Lancet
1 PLoS Med
6 PLoS One
1 Vaccine



    AIDS

  1. WILLIAMS PL, Yu W, Van Dyke RB, Sawyer G, et al
    Longitudinal changes in cardiac structure and function among young adults with perinatal HIV infection or HIV exposure.
    AIDS. 2026 Nov 6:10.1097/QAD.0000000000004636. doi: 10.1097/QAD.0000000000004636
    >> Share

  2. YAP SH, Hisham SF, Loh JSM, Hasmukharay K, et al
    Diagnostic performance of the ICOPE-aligned screening tool for intrinsic capacity in people with HIV: considerations for implementation.
    AIDS. 2026 Nov 6. doi: 10.1097/QAD.0000000000004647.
    >> Share

  3. HUANG C, Shi F, Xia H, Wang K, et al
    Genome-wide associated variants of dementia among people with and without HIV in the all of us research program.
    AIDS. 2026 Nov 6. doi: 10.1097/QAD.0000000000004651.
    >> Share

  4. HATHAWAY CL, Klein S, Guha A, Umutesi G, et al
    Potential impact of the United States President's Emergency Plan for AIDS Relief funding cuts on the HIV and cervical cancer burden in Kenya.
    AIDS. 2026 Nov 6. doi: 10.1097/QAD.0000000000004640.
    >> Share


    AIDS Res Hum Retroviruses

  5. YAVUZ S, Aksoy A, Ucer S, Kinikli S, et al
    Evaluation of Tetanus Immunity in People Living with HIV: Reassessment of the Booster Dose Schedule.
    AIDS Res Hum Retroviruses. 2026 Nov 13:8892229261507443.
    >> Share

  6. ASSEFA A, Erkihun M, Berhan A, Almaw A, et al
    Determinants of Virological Suppression Among HIV Patients on Antiretroviral Therapy at Debre Tabor Comprehensive Specialized Hospital: A Cross-Sectional Study.
    AIDS Res Hum Retroviruses. 2026 Nov 10:8892229261504555.
    >> Share

  7. HO K, Edick S, Zyhowski A, Swistok A, et al
    A Randomized, Double-Blind Phase 1 Safety and Pharmacokinetic Study of Q-Griffithsin Douche Administered Rectally to HIV-1 Seronegative Adults (the PREVENT Study).
    AIDS Res Hum Retroviruses. 2026 Nov 9:8892229261502024.
    >> Share


    Antimicrob Agents Chemother

  8. COSTA ACC, Lin Y-W, Chandasana H, Collins J, et al
    Population pharmacokinetic analysis of lamivudine (3TC) in HIV-exposed neonates and pediatric participants living with HIV-1 from the IMPAACT 2019 and PETITE studies.
    Antimicrob Agents Chemother. 2026 Nov 10:e0070126. doi: 10.1128/aac.00701.
    >> Share


    Clin Infect Dis

  9. DE PROST N, Bay P, Le Goff M, Preau S, et al
    People With Influenza Requiring ICU Admission During the 2025-2026 Season, Marked by the Emergence of Influenza A(H3N2) Subclade K: A French Prospective Nationwide Cohort Study.
    Clin Infect Dis. 2026 Nov 11:ciag648. doi: 10.1093.
    >> Share

  10. ZHU W, Patel RR, Huang YA, Davis NL, et al
    CAB-LA PrEP Prescriptions and Abandonment in the United States, January 2022-June 2025.
    Clin Infect Dis. 2026 Nov 12:ciag721. doi: 10.1093.
    >> Share


    HIV Med

  11. BACHA Z, Hassan ST, Ali F, Mahrukh M, et al
    HIV/AIDS burden in South Asia, 1990-2023: Temporal trends, sex differences and attributable risk factors from the Global Burden of Disease study 2023.
    HIV Med. 2026 Nov 9. doi: 10.1111/hiv.70362.
    >> Share

  12. BURNS F, Parczewski M, Martinez E
    Beyond borders: Making HIV prevention and care work for people on the move.
    HIV Med. 2026 Nov 10. doi: 10.1111/hiv.70360.
    >> Share

  13. TROYA J, Pousada G, de Los Santos I, Mican R, et al
    Immune outcomes with dolutegravir-based dual therapy versus bictegravir-based triple therapy: A multinomial propensity score analysis.
    HIV Med. 2026 Nov 12. doi: 10.1111/hiv.70365.
    >> Share

  14. MOSCHESE D, Tediosi F, Fusetti C, Baratelli A, et al
    Estimating the potential need for HIV pre-exposure prophylaxis in Italy: A national modelling study.
    HIV Med. 2026 Nov 8. doi: 10.1111/hiv.70364.
    >> Share

  15. SCONZA R, Fernandes G, Rasi V, Bailey H, et al
    Pregnancy and neonatal outcomes after prenatal exposure to dolutegravir: Data from a European cohort collaboration.
    HIV Med. 2026 Nov 8. doi: 10.1111/hiv.70359.
    >> Share

  16. OGUL Z, Yakit Ak E, Tandogan O
    Structural determinants of outcomes related to the prevention of vertical HIV transmission: A cross-country ecological analysis.
    HIV Med. 2026 Nov 8. doi: 10.1111/hiv.70361.
    >> Share

  17. LAGI F, Rossetti B, Fabbiani M, Nigi D, et al
    Applying the CONSENSUS-LAI virological failure definition in real-world practice: Evidence from the multicentre LAHIV cohort.
    HIV Med. 2026 Nov 6. doi: 10.1111/hiv.70363.
    >> Share


    J Acquir Immune Defic Syndr

  18. MOROJELE NK, Yeo YR, Shenoi S, Jeetoo M, et al
    Modelling minimum resource requirements to reach Ending the HIV Epidemic (EHE) goal in KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2026 Nov 9. doi: 10.1097/QAI.0000000000004000.
    >> Share

  19. CHAGOMERANA MB, Mubiru KR, Adams SV, Moser CB, et al
    Brief Report: Prognostic Value of Kaposi Sarcoma Herpes Virus-Associated Clinical Symptom Scores in HIV-Associated Kaposi Sarcoma.
    J Acquir Immune Defic Syndr. 2026;101:1378-1383.
    >> Share

  20. HAM L, Franklin DR, Ellis RJ, Letendre S, et al
    Development and Internal Validation of a Two-Year Prognostic Risk Index for Functional Decline in Adults Aging with HIV.
    J Acquir Immune Defic Syndr. 2026 Nov 13. doi: 10.1097/QAI.0000000000003990.
    >> Share


    J Clin Invest

  21. LIU N, Nardo D, Bhardwaj V, Glover J, et al
    HIV-resistant CD19/HIV-targeted dual CAR T cells control HIV replication and B cell lymphoma concurrently in humanized mice.
    J Clin Invest. 2026 Nov 10:e211637. doi: 10.1172/JCI211637.
    >> Share


    J Infect Dis

  22. HARGROVE S, Sterling RK
    Beyond Steatosis: HIV-Associated Liver Fibrosis and the Limits of Current Screening Algorithms.
    J Infect Dis. 2026 Nov 7:jiag552. doi: 10.1093.
    >> Share


    J Virol

  23. SHIMIZU R, Jonathan M, Terasawa H, Saito A, et al
    APOBEC3 antagonism fully explains HIV-1 Vif essentiality in THP-1 cells under interferon and differentiation conditions.
    J Virol. 2026 Nov 10:e0067126. doi: 10.1128/jvi.00671.
    >> Share

  24. KITZROW JP, Kanlong JG, Nikolaitchik OA, Chameettachal A, et al
    HIV-1 excludes non-guanosine nucleotides in major transcription start sites to ensure distinct unspliced RNA fates.
    J Virol. 2026 Nov 12:e0113826. doi: 10.1128/jvi.01138.
    >> Share

  25. RUIZ-GARCIA C, Perez-Godoy MD, Rivera AJ, Martinez-Barbero R, et al
    Baseline immune transcriptional states predict future HIV-1 acquisition in individuals at risk of sexual infection.
    J Virol. 2026 Nov 12:e0137926. doi: 10.1128/jvi.01379.
    >> Share


    Lancet

  26. GIANELLA S, Hunt PW
    The overlooked role of CMV in pneumonia in infants with HIV.
    Lancet. 2026;408:2042-2043.
    >> Share

  27. VAN DER ZALM MM, Barday MA
    Empirical tuberculosis treatment in infants living with HIV: missed opportunities and ways to improve outcomes.
    Lancet. 2026;408:2044-2046.
    >> Share

  28. DOMINGUEZ-RODRIGUEZ S, Tagarro A, Moraleda C, Buck WC, et al
    Empirical tuberculosis treatment in infants living with HIV hospitalised with severe pneumonia in Africa (EMPIRICAL): a multicentre, randomised, open-label, 2 x 2 factorial, controlled superiority trial.
    Lancet. 2026;408:2109-2124.
    >> Share


    PLoS Med

  29. AFRANE AKA, Ahun MN
    Beyond the child: Integrating caregiver mental health into paediatric HIV and tuberculosis care in Africa.
    PLoS Med. 2026;23:e1005287.
    >> Share


    PLoS One

  30. LIONEL GJ, Binnington B, Wong RW, Jin J, et al
    A cell line model for the study of CD4-negative HIV-1 infection and latent virus reservoirs.
    PLoS One. 2026;21:e0361655.
    >> Share

  31. JARSO H, Asu R, Negawo S, Ahmed K, et al
    Viral suppression among adolescents and adults living with human immunodeficiency virus in Ethiopia during the test-and-treat era.
    PLoS One. 2026;21:e0362375.
    >> Share

  32. IFEORAH IM, Chinwendu J, Eneh SC, Olakunde BO, et al
    Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria.
    PLoS One. 2026;21:e0360438.
    >> Share

  33. NTIYANI N, Letamo G, Keetile M, Disang M, et al
    Cardiovascular disease risk prediction models for people living with HIV in Sub-Saharan Africa: A scoping review protocol.
    PLoS One. 2026;21:e0352716.
    >> Share

  34. BARQAWI HJ, Samara KA, Sheiko AR, Alhariri M, et al
    HIV/AIDS knowledge and stigmatizing attitudes among adult residents of the United Arab Emirates: A cross-sectional study.
    PLoS One. 2026;21:e0362376.
    >> Share

  35. KASENDWA M, Nantale R, Kusolo R, Mayega RW, et al
    Fruit and vegetable consumption among people living with HIV at a large Urban HIV Clinic in Central Uganda: A cross-sectional study.
    PLoS One. 2026;21:e0361755.
    >> Share


    Vaccine

  36. HOFMEISTER MG, Yankey D, Elam-Evans LD, Trahan AW, et al
    Hepatitis A vaccination coverage among adolescents aged 13-17?years, United States, 2024.
    Vaccine. 2026;96:129343.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016